Endothelin-B receptor blockade inhibits molecular effectors of melanoma cell progression

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Rosanò, Laura ^a   Spinella, Francesca ^a   Genovesi, Giulia ^a   Di Castro, Valeriana ^a   Natali, Pier Giorgio ^a   Bagnato, Anna ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Adhesion molecules; Endothelin (ET); Endothelin B (ETB) receptor; Invasion; Melanoma

Indexed keywords

4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; ALPHA CATENIN; BETA CATENIN; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; MESSENGER RNA; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER GROWTH; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION;

ALPHA CATENIN; ANTINEOPLASTIC AGENTS; BETA CATENIN; CADHERINS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DISEASE PROGRESSION; DOWN-REGULATION; ENDOTHELIN-1; ENDOTHELIN-3; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; OLIGOPEPTIDES; PIPERIDINES; RECEPTOR, ENDOTHELIN B; RNA, MESSENGER;

EID: 11144281392     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166247.35992.dd     Document Type: Conference Paper

References (27)

1. Shin MK, Levorse JM, Ingram RS, et al The temporal requirement for endothelin receptor-B signalling during neural crest development. Nature. 1999;402:496-501.
2. Herlyn M, Berking C, Li G, et al. Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation. Melanoma Res. 2000;10:303-312.
3. Levin ER. Endothelins. N Engl J Med. 1995;333:356-363.
4. Reid K, Turnley AM, Maxwell GD, et al. Multiple roles for endothelin in melanocyte development: regulation of progenitor number and stimulation of differentiation. Development. 1996;122:3911-3919.
5. Scott G, Cassidy L, Abdel-Malek Z. α-Melanocyte-stimulating hormone and endothelin-1 have opposing effects on melanocyte adhesion, migration, and pp125FAK phosphorylation. Exp Cell Res. 1991;237:19-28.
6. Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem. 1992;267:24675-24680.
7. Tada A, Suzuki I, Im S, et al. Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth & Different. 1998;9:575-584.
8. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol. 1995;105:32-37.
9. Nelson J, Bagnato A, Battistini B, et al. The endothelin axis: emerging role in cancer. Nat Rev Cancer. 2003;3:110-116.
10. Yohn JJ, Smith C, Stevens T, et al. Human melanoma cells express functional endothelin-1 receptors. Biochem Biophys Res Commun. 1994;201:449-457.
11. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 2000;406:536-540.
12. Demunter A, De Wolf-Peeters C, Degreef H, et al. Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma. Virchows Arch. 2001;438:485-491.
13. Eberle J, Fecker LF, Orfanos CE, et al. Endothelin-1 decreases basic apoptotic rates in human melanoma cell lines. J Invest Dermatol. 2002;119:549-555.
14. Lahav R, Heffner G, Patterson PH. An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo. Proc Natl Acad Sci U.S.A. 1999;96:11496-11500.
15. Li G, Satyamoorthy K, Meier F, et al. Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil. Oncogene. 2003;2:3162-3171.
16. Jamal S, Schneider RJ. UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells. J Clin Invest. 2002;110:443-452.
17. Bagnato A, Rosano L, Spinella F, et al. Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression. Cancer Res. 2004;64:1436-1443.
18. Ruiter D, Bogenrieder T, Elder D, et al. Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol. 2002;3:35-43.
19. Bullions LC, Notterman DA, Chung LS, et al. Expression of wild-type α-catenin with a mutant α-catenin gene restores both growth regulation and tumor suppressor activities. Mol Cell Biol. 1997;17:4501-4508.
20. Ewing CM, Ru N, Morton RA, et al. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with repression of α-catenin and restoration of E-cadherin function. Cancer Res. 1995;55:4813-4817.
21. Watabe M, Nagafuchi A, Tsukia S, et al. Induction of polarized cell-cell association and retardation of growth by activation of E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol. 1994;127:247-251.
22. Morin PJ. B-catenin signaling and cancer. BioEssays. 1999;21:1021-30.
23. Poser I, Dominguez D, Garcia de Herreros G, et al. Loss of E-cadherin expression in melanoma cells involves upregulation of the transcriptional repressor Snail. J Biol Chem. 2001;276:24661-24666.
24. Rivedal E, Opsahl H. Role of PKC and MAP kinase in EGF- and TPA-induced connexin43 phosphorylation and inhibition of gap junction intercellular communication in rat liver epithelial cells. Carcinogenesis. 2001;22:1543-1550.
25. Kahana O, Micksche M, Witz IP, et al. The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma. Oncogene. 2002;21:3969-3977.
26. Satyamoorthy K, Li G, Gerrero MR, et al. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res. 2003;63:756-759.
27. Smalley KSM. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma. Int J Cancer. 2003;104:527-532.